Switch to:
Genomic Health Inc (NAS:GHDX)
EV/EBITDA
-47.78 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Genomic Health Inc's enterprise value is $926.3 Mil. Genomic Health Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2014 was $-19.4 Mil. Therefore, Genomic Health Inc's EV/EBITDA ratio for today is -47.78.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Genomic Health Inc's stock price is $32.50. Genomic Health Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2014 was $-0.89. Therefore, Genomic Health Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Genomic Health Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=926.263/-19.384
=-47.78

Genomic Health Inc's current Enterprise Value is $926.3 Mil.
Genomic Health Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2014 was -6.941 (Dec. 2013 ) + -5.437 (Mar. 2014 ) + -2.878 (Jun. 2014 ) + -4.128 (Sep. 2014 ) = $-19.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Genomic Health Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=32.50/-0.893
=

Genomic Health Inc's share price for today is $32.50.
Genomic Health Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2014 was -0.303 (Dec. 2013 ) + -0.24 (Mar. 2014 ) + -0.15 (Jun. 2014 ) + -0.2 (Sep. 2014 ) = $-0.89.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Genomic Health Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebitda 0.00-6.58-15.39-22.35-46.30-235.2748.4942.0851.54-145.40

Genomic Health Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2ebitda 59.4562.9951.5462.17111.02167.03-145.40-62.10-57.57-40.93
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK